TY  - JOUR

T1  - Sarilumab for Previously-Treated Moderate or Severe Rheumatoid Arthritis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

JO  - Pharmacoeconomics

UR  - https://eprints.whiterose.ac.uk/id/eprint/131862

PY  - 2018/06/08

AU  - Bermejo I

AU  - Ren S

AU  - Simpson E

AU  - Clowes M

AU  - Scott DL

AU  - Young A

AU  - Stevenson M

ED  - 

DO  - DOI: 10.1007/s40273-018-0677-7

PB  - Springer Nature

VL  - 36

IS  - 12

SP  - 1427

EP  - 1437

Y2  - 2024/10/18

ER  -